DOCSLIB.ORG

Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities Editorial Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities The PLoS Medicine Editors* Almost ten years ago, activism and upon an extensive and consultative process and works against the duty to promote public protest resulted in a landmark with multiple stakeholders—include re- human rights—as the company that holds victory for the access to medicines move- sponsibilities for transparency, manage- the patent is basically the only entity that ment, when 39 of the world’s leading ment, monitoring and accountability, pric- can legally do so’’ [8]. At the same time pharmaceutical companies dropped their ing, and ethical marketing. They identify that the 825 billion dollar global pharma- collective lawsuit against the South African best practice as including access to med- ceutical industry operates as society’s chief government for attempting to legalize the icines, differential pricing between and developer and purveyor of life-saving importation of cheaper generic versions of within countries, commercial voluntary medicine, two billion people around the drugs [1]. Following a settlement, medica- licensing that allows for the production of world lack access to essential medicines. tion prices—including those for antiretro- cheaper generics, investment into research Such a persistent perversity demands more virals to treat the millions of South and development (R&D) of neglected outrage. Africans with HIV/AIDS—dropped, and diseases, and engagement in public–pri- Unfortunately, the pharmaceutical com- public pressure on the pharmaceutical vate partnerships. The Guidelines also panies that now do acknowledge the industry was hailed a success [2]. A decade recommend against lobbying for more importance of principles related to human later it’s time again for action—to hold protection in intellectual property laws, rights tend to blunt their own responsibil- drug companies accountable for their applying for patents for trivial modifica- ities by instead emphasizing their corporate human rights responsibilities to make tions of existing medicines, inappropriate social responsibility initiatives, employment medicines available and accessible to those drug promotion, and excessive pricing. standards, global health programmes, and in need. Indeed, a most notable aspect of the Hunt participation in drug donation schemes, As part of this effort, PLoS Medicine Report is its revelation that many of the voluntary price reductions, or international publishes three unique perspectives on the obstacles States face in delivering the right business groups like the UN Global Com- question of whether drug companies are to health to their citizens are created by pact and the Business Leaders Initiative on living up to their human rights responsi- these very drug company practices [7]. Human Rights (BLLIHR) [9–12]—not bilities. Sofia Gruskin and Zyde Raad The chief proposition in the Guidelines explicitly human rights activities. Indeed, from the Harvard School of Public Health is that pharmaceutical companies, by there is danger in pharmaceutical compa- say more assessment is needed of such virtue of being granted by society the nies’ persistent assertions that the primary obligations [3]; Geralyn Ritter, Vice monopoly and power to develop medi- responsibility for delivering the right to President of Global Health Policy and cines, hold that power (the patent) with health lies with the State and that their role Corporate Social Responsibility at Merck express conditions. And these conditions is merely supportive—as reflected in the & Co., argues that multiple stakeholders include human rights responsibilities to Merck perspective published today in PLoS could do more to help States deliver the make medicines available and accessible. Medicine [4]—as this argument allows the right to health [4]; and Paul Hunt and As Hans Hogerzeil, WHO Director of industry to exculpate itself from its own Rajat Khosla offer their reflections [5] on Essential Medicines and Pharmaceutical human rights responsibilities. Mr. Hunt’s work as the UN Special Rapporteur on the right to the highest Policies, was quoted recently as saying, not Klaus Leisberger, President of the attainable state of health (2002–2008), providing new drugs available to those Novartis Foundation for Sustainable which culminated in the first ‘‘Human who need them ‘‘breaks the social contract Development, is a leading advocate of Rights Guidelines for Pharmaceutical Companies’’ [6]. This PLoS Medicine De- Citation: The PLoS Medicine Editors (2010) Drug Companies Should Be Held More Accountable for Their bate comes two years after the release of Human Rights Responsibilities. PLoS Med 7(9): e1000344. doi:10.1371/journal.pmed.1000344 the Guidelines and a year after Mr. Hunt’s Published September 28, 2010 report [7] on his invited mission to review Copyright: ß 2010 PLoS Medicine Editors. This is an open-access article distributed under the terms of the the policies and practices of GlaxoS- Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any mithKline (GSK) was submitted to the medium, provided the original author and source are credited. UN Human Rights Council. Together Funding: The authors are each paid a salary by the Public Library of Science, and they wrote this editorial these perspectives and reports make clear during their salaried time. that the responsibilities of pharmaceutical Competing Interests: The authors’ individual competing interests are at http://www.plosmedicine.org/static/ editorsInterests.action. PLoS is funded partly through manuscript publication charges, but the PLoS Medicine companies go beyond stakeholder value to Editors are paid a fixed salary (their salary is not linked to the number of papers published in the journal). encompass human rights. What is also Abbreviations: GSK, GlaxoSmithKline; R&D, research and development. clear is that more accountability is now needed. * E-mail: [email protected] The Guidelines on human rights re- The PLoS Medicine Editors are Virginia Barbour, Jocalyn Clark, Susan Jones, and Emma Veitch. sponsibilities of drug companies—based Provenance: Written by editorial staff; not externally peer reviewed. PLoS Medicine | www.plosmedicine.org 1 September 2010 | Volume 7 | Issue 9 | e1000344 corporate social responsibility among Pfizer and Gilead emerging as the most monitor and publicly document their own pharmaceutical companies, but neverthe- improved since 2008. The Index concludes activities. We agree. Beyond an add-on or less writes that ‘‘no private enterprise has that many more companies are participat- peripheral activity, the acknowledgement the societal mandate or the organizational ing in initiatives to improve access to and promotion of human rights must capabilities to feed the poor or provide medicines and are becoming more trans- become a regular, integrated aspect of health care to the sick’’ [13]. ‘‘Enlight- parent and cooperative in sharing informa- the work of pharmaceutical companies. ened’’ pharmaceutical companies, he says, tion but that the need for medicines across a Better yet would also be an external, can respect and even protect the right to range of infectious and non-communicable international body charged explicitly with health of their employees, for example. diseases remain substantial and is growing. monitoring the policies and practices of But beyond that, in terms of delivering the (Notably, the Index does not examine pharmaceutical companies and reporting right to health, he argues that this company performance against best practic- publicly on the discharge of their right-to- responsibility ‘‘cannot be more than a es, but instead against other companies.) health responsibilities. very limited contribution to overcoming Other analyses, by the George Institute, The challenge for the pharmaceutical the challenges that we all face on a global the UK Department of International industry is to develop viable business level.’’ And indeed major companies in Development, and others [5] demonstrate models that allow for profit whilst respect- their responses to the Guidelines argued some progress in access to medicines and ing and promoting human rights. Phar- that their role and human rights respon- many areas where improvement is needed. maceutical companies are tremendously sibilities are not adequately defined But none of these audits, including the innovative entities that abhor bad public- [14,15]. In contrast, independent observ- Access to Medicine Index, ‘‘frame the ity, so the incentive is there for stimulating ers have stated that these expectations are performance indicators in human rights creative thinking under public pressure. in fact well delineated [16]. terms’’ and none ‘‘explicitly advocate a The human rights guidelines and respon- So how well are drug companies doing? requirement for accountability against sibilities are now clear; the monitoring and Several exercises are available that shed human rights standards,’’ emphasised Paul accountability must step up in earnest. some light on the question. The most Hunt in an interview with PLoS Medicine. important of these, the Access to Medicines What type of accountability is needed? Index (http://www.accesstomedicineindex. The importance and significance of Acknowledgments org/), provides an unprecedented and accountability in this area cannot be Many thanks to Paul Hunt and Gavin Yamey independent comparative analysis of 27 overstated. As Helen
Load more

Recommended publications
  • A Catalogue of Reporting Guidelines for Health Research REVIEW
    DOI: 10.1111/j.1365-2362.2009.02234.x REVIEW A catalogue of reporting guidelines for health research I. Simera*, D. Moher†, J. Hoey‡, K. F. Schulz§ and D. G. Altman* *University of Oxford, Oxford, UK, †Ottawa Health Research Institute, Ottawa, ON, Canada, ‡University of Toronto, Toronto, ON, Canada, §UNC School of Medicine, Chapel Hill, NC, USA ABSTRACT Growing evidence demonstrates widespread deficiencies in the reporting of health research studies. The EQUATOR Network is an international initiative that aims to enhance the reliability and value of the published health research literature. EQUATOR provides resources, education and training to facilitate good research reporting and assists in the development, dissemination and implementation of robust reporting guidelines. This paper presents a collection of tools and guidelines available on the EQUATOR website (http://www.equator- network.org) that have been developed to increase the accuracy and transparency of health research reporting. Keywords EQUATOR Network, reporting guidelines, research reporting. Eur J Clin Invest 2010; 40 (1): 35–53 Many scientific articles are written merely to get something reporting of harms [7]; presenting data and graphs in confusing published, neglecting the clinician who would like the medical and misleading ways [8]; and omissions from or misinterpreta- literature to guide their practice [1]. tion of results in abstracts [9]. These deficiencies seriously distort scientific reality [10] and Introduction prevent clinicians from applying effective interventions in patients’ care [5]. Boxes 1 and 2 show just two of the numerous The main purpose of investing money into health research is to examples of problems identified in the research literature.
    [Show full text]
  • WHO/Plos Collection ‘‘No Health Without Research’’: a Call for Papers
    Editorial WHO/PLoS Collection ‘‘No Health Without Research’’: A Call for Papers Tikki Pang1*, Robert F. Terry1, The PLoS Medicine Editors2* 1 World Health Organization, Department of Research Policy and Cooperation, Geneva, Switzerland, 2 PLoS Medicine It seems astonishing that in the 21st research systems [5]. We would then 7. Exercises to evaluate the impact of century decisions on health care can still aim to publish a WHO/PLoS Collection research investments; be made without a solid grounding in culminating in 2012 to coincide with the 8. Experiences with external foreign aid research evidence. This is true even in release of the WHR. Thus, we welcome for research. clinical research, whether for simple or examples of research and/or case studies complex interventions [1], where system- in the following areas. Ideally, studies or reports should not be atic reviews time and time again conclude merely descriptions of activities but should that the evidence base is inadequate [2]. It 1. Experience with setting and imple- include evaluation of the impact of initia- is even more true in the areas of health menting health research priorities; tives after their implementation. Special policy and health systems, where quality 2. Experience with building, strengthen- consideration will also be given to system- research is hampered further by a lack of ing, and retaining research capacity, at atic and well-performed multi-country shared definitions, a lack of consensus on both the individual and institutional comparative studies on the topics men- guiding principles, poor capacity (especial- levels; tioned above, including systematic reviews, ly in low-resource regions), and methodo- 3.
    [Show full text]
  • Download Issue
    SCIENCE DITOR E A Publication of the Council of Science Editors In this issue • Perspectives on Open Access • More 2012 Annual Meeting Reports • 2013 Annual Meeting Program and Short Course Previews JANUARY – MARCH 2013 • VOLUME 36 • NUMBER 1 VIEWPOINT SCIENCE 2 Perspectives on Open Access. PATRICIA K BASKIN EDITOR ARTICLES 3 Open Access Demystified: Flavors, Colors, and Practices in Today’s Scholarly Publishing Marketplace. MORNA CONWAY JANUARY – MARCH 2013 5 Open Acess: Scholarly Publishers Can Take the Lead. DAVID CROTTY VOLUME 36 • NUMBER 1 8 Embracing Open Access. JOYCE-RACHEL JOHN 9 PLOS and the Surge in Global Momentum for Open Access. KRISTEN RATAN Science Editor (ISSN 1535-5365) is published quar- terly by the Council of Science Editors Inc, 10200 11 An Open-Access Future: Challenges and Opportunities for the Humanities and Social W 44th Street, Suite 304, Wheat Ridge, CO Sciences. WILL SCHWEITZER and CHARLES B CHOE 80033, and serves as a forum for the exchange of 13 The American Physical Society’s Experiences in Open-Access Publishing. ideas among professionals concerned with publish- DANIEL T KULP ing in the sciences. We encourage contributions of articles on peer-review research, editorial processes, 14 Evolving Access: Genetics Society of America Journals GENETICS and G3: ethics, and other items of special interest to our Genes|Genomes|Genetics. TRACEY DEPELLEGRIN readers. For more details about submission, see our 16 One Society’s Perspective on Open-Access Publishing. HEATHER GOODELL Information for Contributors page at www.council- 17 PeerJ Heralds in a New Era of Innovation and Affordability in Academic Publishing. scienceeditors.org/i4a/pages/index.cfm?pageID=3369.
    [Show full text]
  • It's the Network, Stupid: Why Everything in Medicine Is Connected
    Editorial It’s the Network, Stupid: Why Everything in Medicine Is Connected The PLoS Medicine Editors ne need look no further the outbreak was tied to a network not emerge from studying individual than Facebook to appreciate of sexual contacts who were meeting behavior. Othe significance and power through Internet chat rooms [2]. The Lewis and colleagues conducted of social networking. (Even PLoS public health department was then able their study because of a seeming has its own thriving Facebook to initiate an electronic awareness and contradiction. Genetic studies of community, which you can join at partner notification campaign using HIV transmission networks have not http://www.facebook.com/group. the same Web-based sexual network; corresponded well with the social php?gid=2401713690.) But social 42% of named partners were identified contact networks revealed through networking is about more than just and evaluated. interview data. The authors’ use of friends reunited; it’s a framework for The observation that social relations phylodynamics—a mix of genetics, understanding even the most basic of and interdependency play a part in epidemiology, and evolutionary biological processes. Two papers in health is not surprising. But what biology—allowed a more sophisticated this month’s PLoS Medicine illustrate network theory teaches us is that look. By examining and dating the the insight that network theory brings connections, even within the most genetic sequences of men attending to basic science, and the valuable complex systems, are not random (that an HIV clinic in central London, Lewis interdisciplinarity that social network is, they are not unpredictable).
    [Show full text]
  • Has the Global Health Agenda Become Too Medicalized?
    Global Health Action ISSN: 1654-9716 (Print) 1654-9880 (Online) Journal homepage: https://www.tandfonline.com/loi/zgha20 Medicalization of global health 1: has the global health agenda become too medicalized? Jocalyn Clark To cite this article: Jocalyn Clark (2014) Medicalization of global health 1: has the global health agenda become too medicalized?, Global Health Action, 7:1, 23998, DOI: 10.3402/gha.v7.23998 To link to this article: https://doi.org/10.3402/gha.v7.23998 © 2014 Jocalyn Clark View supplementary material Published online: 16 May 2014. Submit your article to this journal Article views: 1827 View related articles View Crossmark data Citing articles: 13 View citing articles Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=zgha20 Global Health Action æ MEDICALIZATION OF GLOBAL HEALTH Medicalization of global health 1: has the global health agenda become too medicalized? Jocalyn Clark1,2* 1Communications & Development Unit, icddr,b, Dhaka, Bangladesh; 2Department of Medicine, University of Toronto, Toronto, Canada Medicalization analyses have roots in sociology and have critical usefulness for understanding contemporary health issues including the ‘post-2015 global health agenda’. Medicalization is more complex than just ‘disease mongering’ Á it is a process and not only an outcome; has both positive and negative elements; can be partial rather than complete; and is often sought or challenged by patients or others in the health field. It is understood to be expanding rather than contracting, plays out at the level of interaction or of definitions and agenda-setting, and is said to be largely harmful and costly to individuals and societies.
    [Show full text]
  • Health Knowledge Commons”: Open Access, Human Rights, and What the Commons Means for Researchers and Editors
    Annual Meeting Reports Building the “Health Knowledge Commons”: Open Access, Human Rights, and What the Commons Means for Researchers and Editors Moderator: who can afford it. That paradigm helps and independent, the journal has published Gavin Yamey to fuel the $5 billion scientific and medi- 42 articles and has an acceptance rate of PLoS Medicine, PLoS Neglected cal publishing industry and can be consid- about 20%. Tropical Diseases ered a public-health crisis because restrict- Anita Palepu presented recent OA poli- San Francisco, California ing access to biomedical knowledge can cies. In December 2007, the United States have life-or-death consequences. Arguing passed a bill requiring researchers funded by Speakers: that scientific knowledge is a human right, the National Institutes of Health to submit Anita Palepu Yamey cited multiple international initia- all final peer-reviewed journal manuscripts Open Medicine tives, including Article 27, Section 1, of to PubMed Central on the day of publication Vancouver, British Columbia the UN’s Universal Declaration of Human and to make them freely available within 12 Rights: “Everyone has the right freely to months. The European Research Council Claire Kendall . share in scientific advancement and its (ERC) requires all peer-reviewed publica- Open Medicine benefits.” Medical research findings should tions arising from ERC-funded research to Ottawa, Ontario be considered a “global public good,” says be placed in a repository (such as PubMed Yamey, especially because most research is Central) on publication and made OA with- Jocalyn Clark funded by the public. in 6 months. Palepu also described the new PLoS Medicine With the advent of the Internet, the OA mandate at Harvard University—the Toronto, Ontario proposed solution is to make all research first of its kind at the US university level.
    [Show full text]
  • Print This Article
    Editorial The Future of Academic Medicine Ana Marušić Croatian Medical Journal Note: This editorial was prepared from the published articles Zagreb University School of Medicine, on ICRAM activities and the Power Point presentation on Zagreb, Croatia the five scenarios of futures of academic medicine in 2025, prepared by Dr Jocalyn Clark, British Medical Journal. The presentation of the scenarios was used by the author of this editorial for lectures on several occasions, including the Sym- Corresponding author: posium on “Gefährdung der univerisitären Medizin”, Neue Ana Marušić Universität Heidelberg, 22 July 2005; 10th “Grazer Konferenz” Salata 3 on “Curriculum Development as an Ongoing Process” in Vi- 10000 Zagreb enna, 11-13 May 2006; and the Symposium on “Ethics and Croatia Medicine: Today and Tomorrow” in Zagreb, 24 November e-mail: [email protected] 2006. Received: 05. 09. 2006 Key words: Education, Medical; Schools, Medical; Biomedical Accepted: 25. 09. 2006 Research; Evidence-Based Medicine; Bosnia-Herzegovina. Academic medicine is usually defined as a cal Sciences in the UK, published in 2002 triad of teaching, research and practice in its report “Clinical Academic Medicine in medicine (1, 2). More broadly, it can be de- Jeopardy: Recommendations for Change”; fined as the “capacity of the health-care sys- and the American Association of Medical tem to think, study, research, discover, eval- Colleges released in 2004 their analysis of uate, innovate, teach, learn, and improve” medical education system in the USA, en- (3). Although these attributes of academic titled “Educating Doctors to Provide High medicine make it crucial for the improve- Quality Medical Care: A Vision for Medical ment of health, there are many voices in the Education in the United States” (3).
    [Show full text]
  • Ten Myths Around Open Scholarly Publishing Jonathan P
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Copyright, Fair Use, Scholarly Communication, etc. Libraries at University of Nebraska-Lincoln 3-11-2019 Ten Myths around Open Scholarly Publishing Jonathan P. Tennant IGDORE, Leicester, United Kingdom, [email protected] Harry Crane Rutgers University - New Brunswick/Piscataway, [email protected] Tom Crick Swansea University Jacinto Davila Universidad de Los Andes, Bogotá, Venezuela Asura Enkhbayar Simon Fraser University See next page for additional authors Follow this and additional works at: http://digitalcommons.unl.edu/scholcom Part of the Intellectual Property Law Commons, Scholarly Communication Commons, and the Scholarly Publishing Commons Tennant, Jonathan P.; Crane, Harry; Crick, Tom; Davila, Jacinto; Enkhbayar, Asura; Havemann, Johanna; Kramer, Bianca; Martin, Ryan; Masuzzo, Paola; Nobes, Andy; Rice, Curt; López, Bárbara R.; Ross-Hellauer, Tony; Sattler, Susanne; Thacker, Paul; and Vanholsbeeck, Marc, "Ten Myths around Open Scholarly Publishing" (2019). Copyright, Fair Use, Scholarly Communication, etc.. 98. http://digitalcommons.unl.edu/scholcom/98 This Article is brought to you for free and open access by the Libraries at University of Nebraska-Lincoln at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Copyright, Fair Use, Scholarly Communication, etc. by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Authors Jonathan P. Tennant, Harry Crane, Tom Crick, Jacinto
    [Show full text]
  • WORLD HEALTH SUMMIT, Regional Meeting-Africa 2021 Kampala, Uganda
    WORLD HEALTH SUMMIT, Regional Meeting-Africa 2021 Kampala, Uganda PANEL DISCUSSION 15, Migrant and Refugee Health Organized by the M8 Alliance under the leadership of the Sapienza University of Rome, and co-hosted by Lancet Migration and Makerere University Migrant and Refugee Health: An Agenda for Africa TUESDAY June 29, 2021 16:30 – 18:00 Eastern African Time (i.e. GMT+ 3) Free Registration: https://docs.google.com/forms/d/e/1FAIpQLSc5- ESawzQiUABlQcKhXQyQaonUHGWrox7SRsGEwTBhkNfUfQ/viewform PROGRAM Time Item Speakers 16:30-16:35 Welcome Luciano Saso. Sapienza University of Rome, Coordinator M8 Alliance Webinar Series on Migrant and Refugee Health 16:35-17:35 Panel chaired by Jocalyn Clark, Executive Editor at The Lancet Discussion “Key migratory trends in Africa, and the place of migrants’ and displaced people’s health in the agenda for development “Africa 2063”. Geoffrey Wafula Kundu. AUC-African Union Commission; Migration Coordinator. “Towards a sustainable Migrant and Refugee Health agenda for the WHO African Region”. Abdou Salam Gueye. WHO-World Health Organization/Regional Office for Africa, Regional Emergency Director (RED) “Building a health agenda within migration governance and response to displacement in Africa: the experience of the IOM”. Mohammed Abdiker IOM-International Organization for Migration/Regional Office for Eastern Africa and the Horn, Director; former IOM Director Emergencies/HQ “IFRC’s route-based approach to promoting migrants’ access to services” Florine Clomegah, IFRC-International Federation Red Cross/Red Crescent, Deputy Director for the Africa Region “The health of children on the move in Africa”. Doris Mpoumou, Director and Africa Union Representative – Save the Children Global Advocacy office Addis Abeba “The Role of African Universities in Capacity Building for Research and training in migration and health: the case of Makerere University”.
    [Show full text]
  • Download This File
    This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues. Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited. In most cases authors are permitted to post their version of the article (e.g. in Word or Tex form) to their personal website or institutional repository. Authors requiring further information regarding Elsevier’s archiving and manuscript policies are encouraged to visit: http://www.elsevier.com/copyright Author's personal copy Opinion Towards a framework for community engagement in global health research James V. Lavery1,2,3, Paulina O. Tinadana3, Thomas W. Scott4, Laura C. Harrington5, Janine M. Ramsey6, Claudia Ytuarte-Nun˜ ez4 and Anthony A. James7 1 Centre for Research on Inner City Health & Centre for Global Health Research, Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Canada 2 Dalla Lana School of Public Health and Joint Centre for Bioethics, University of Toronto, Toronto, M5B 1W8, Canada 3 Program on Ethics and Commercialization, McLaughlin-Rotman Centre for Global Health Research, University Health Network and University of Toronto, Toronto, M5G 1L7, Canada 4 Department of Entomology, University of California, Davis, California, USA 5 Department of Entomology, Cornell University, Ithaca, NY 14853, USA 6 National Institute of Public Health, Tapachula, Chiapas 30700, Mexico 7 Departments of Microbiology & Molecular Genetics and Molecular Biology & Biochemistry, University of California, Irvine, CA 92697, USA New technologies for global public health are spurring what makes them effective is still determined largely by a critical evaluations of the role of communities in combination of intuition, experience and opinion.
    [Show full text]
  • Wednesday, 3 March , DAY 1
    2nd Global Consultation on Migrant Health: Resetting the Agenda Jointly Organized by IOM, WHO and the Government of the Democratic Socialist Republic of Sri Lanka Colombo, Sri Lanka 21-23 February 2017 Agenda Tuesday 21 February – DAY 1 07:00-9:00 Registration 09:00 - 9:15 OPENING: CEREMONIAL PROCESSION, LIGHTING OF THE OIL LAMP AND NATIONAL ANTHEM 09:15 – 09:45 WELCOME ADDRESS BY ANURA JAYAWICKRAMA, SECRETARY, MINISTRY OF HEALTH, NUTRITION & INDIGENOUS MEDICINE, SRI LANKA KEYNOTE ADDRESS BY HON. DR RAJITHA SENARATNE, MINISTER OF HEALTH, NUTRITION & INDIGENOUS MEDICINE, SRI LANKA STATEMENTS VIA VIDEO BY AMBASSADOR WILLIAM L. SWING, DIRECTOR GENERAL, IOM & DR. MARGARET CHAN, DIRECTOR GENERAL, WHO 09:45-10:30 SETTING THE SCENE Despite known linkages between Migration and Health, international human rights standards, a 2008 World Health Resolution on Migrant Health, and the recognized role of migrants for sustained social and economic development, the process has been slow in meeting the health needs of migrants, adjust and develop conducive policies across sectors, and equip health systems to respond to contemporary migration and human mobility. The Consultation objectives, underlying conceptual framework and intended outcomes will be presented against a background of Global Health and Global Migration Initiatives emphasizing recent milestones and near future key processes to jointly work towards. Chair: Hon. Dr Rajitha Senaratne, Minister of Health, Nutrition & Indigenous Medicine, Sri Lanka Speakers: Davide Mosca, Director, Migration Health Division, IOM & Kanokporn Kaojaroen, Migration and Health Officer, WHO Discussion 10:30-10:45 Coffee Break Session I: Global Health PLENARY SESSION WITH PANEL AND DISCUSSION 10:45-11:30 Ensure health and well-being for all, in line with the achievement of Universal Health Coverage, through financial risk protection, access to quality essential health-care services, prevention and health promotion is the overarching health-related approach of the Development Agenda 2030.
    [Show full text]
  • Sociology of Health and Illness
    SOC 6022H Sociology of Health & Illness Summer 2018 (Mid-May to end of June: Mon & Thurs, 10am-Noon) Instructor: William Magee, Associate Professor Medical sociologists worK in diverse settings (e.g. NGOs, hospitals, public health organizations, academic departments at universities, etc.). Research in the field also employs many different methods and theoretical orientations. This course surveys select aspects of the broad field of medical sociology with an emphasis on illness etiology, distribution, and the experience of illness. We start out by examining historical trends in epidemiologic patterns in relation to medical and public health practices, and medicalization. Both progress (e.g., global reductions in child mortality), and iatrogenesis (e.g., increased mortality among large population segments due to over-prescription of opiates) can be observed, and this has implications for the requisite complexity of theory. We then consider health and illness over the life course. Emerging findings from research that investigates how biological and psychosocial factors are intertwined begs questions about the relation between causal models, paradigms, theories, and policies. Policies (under liberalism) are often loosely related to action, so we focus in particular on the material bases for action. Some action is governmental, some is extra-governmental though political, and some is private or situational. With respect to the latter, we will consider the argument that new individualized forms of health-related practices (e.g., “disciplinary projects of the self”) reflect broader shifts in the construction of what it means to be human, and agentic. Illness can shape human agency, as well as portend the end of agency. In the final sessions, we will consider these issues by focusing on the self, and the phenomenology of illness experience, in both physical and mental manifestations.
    [Show full text]